Therapeutic Insights of Entomopathogenic Mycotoxins in Breast Cancer Cells

dc.contributor.authorPatra, Arupam
dc.date.accessioned2024-12-13T10:12:23Z
dc.date.available2024-12-13T10:12:23Z
dc.date.issued2024
dc.descriptionSupervisors: Saini, Gurvinder Kaur and Ghosh, Siddhartha Sankar
dc.description.abstractChemotherapeutic resistance in breast cancer, especially in aggressive forms like triple-negative breast cancer (TNBC), presents a major obstacle in treatment, driving the search for more effective therapeutic agents. TNBC is marked by high mortality rates and limited treatment options, underscoring an urgent need for targeted therapies. Researchers have focused on unique fungalderived compounds with anticancer properties that may offer novel approaches to overcome drug resistance and directly targeting cancer cell survival mechanisms. Two such compounds, the ribotoxin Anisoplin and the secondary metabolite Beauvericin, have demonstrated promising effects against breast cancer, especially in TNBC, where they can potentially overcome resistance and induce cell death through unique molecular pathways.
dc.identifier.otherROLL NO.186106116
dc.identifier.urihttps://gyan.iitg.ac.in/handle/123456789/2772
dc.language.isoen
dc.relation.ispartofseriesTH-3487
dc.titleTherapeutic Insights of Entomopathogenic Mycotoxins in Breast Cancer Cells
dc.typeThesis
Files
Original bundle
Now showing 1 - 2 of 2
No Thumbnail Available
Name:
Abstract-TH-3487_186106116.pdf
Size:
163.43 KB
Format:
Adobe Portable Document Format
Description:
ABSTRACT
No Thumbnail Available
Name:
TH-3487_186106116.pdf
Size:
26.06 MB
Format:
Adobe Portable Document Format
Description:
THESIS
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: